Methods for identification and prediction of multiple sclerosis disease and therapy response

Details for Australian Patent Application No. 2009292905 (hide)

Owner University of Utah Research Foundation Lineagen, Inc.

Inventors Rose, John W.; Leppert, Mark F.

Agent Spruson & Ferguson

Pub. Number AU-A-2009292905

PCT Pub. Number WO2010/033951

Priority 61/098,650 19.09.08 US

Filing date 21 September 2009

Wipo publication date 25 March 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

13 January 2011 PCT application entered the National Phase

  PCT publication WO2010/033951 Priority application(s): WO2010/033951

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009292906-Configuration and tracking of 2-D modular heliostat

2009292892-Seed treatment agent and method for protecting plant